United States · FDA National Drug Code directory
Hadlima
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 78206-185_28a18c27-7052-4b4d-af4e-d81048f424e8
- Product NDC
- 78206-185
- Form
- SOLUTION
- Composition / generic term
- adalimumab-bwwd
- Labeler
- Organon LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230701
- Source listing expiry
- 20271231
Source-listed ingredients
- ADALIMUMAB — 40 mg/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTON in 1 CARTON (78206-185-01) / 1 VIAL in 1 CARTON (78206-185-99) / .8 mL in 1 VIAL · 78206-185-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →